Xencor (XNCR) Net Margin Growth (5y) (2018 - 2026)

Xencor (XNCR) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xencor 1.47 Bn 1.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -284,778.00
Dec 31, 2025 915.00
Sep 30, 2025 675.00
Jun 30, 2025 19,685.00
Mar 31, 2025 -12,375.00
Dec 31, 2024 67,790.00
Sep 30, 2024 -21,960.00
Jun 30, 2024 -20,542.00
Mar 31, 2024 -53,482.00
Dec 31, 2023 10,580.00
Sep 30, 2023 -5,184.00
Dec 31, 2022 -8,016.00
Sep 30, 2022 19,949.00
Jun 30, 2022 -5,070.00
Mar 31, 2022 46,974.00
Dec 31, 2021 293.00
Sep 30, 2021 -10,092.00
Jun 30, 2021 -33,992.00
Mar 31, 2021 8,091.00
Dec 31, 2020 -6,837.00